LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
NEW ORLEANS, LA / ACCESSWIRE / November 1, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 16, 2024 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NasdaqGS:ACHC), if they purchased the Company's securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period").
RADNOR, PA / ACCESSWIRE / November 1, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ:ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Acadia Healthcare losses, you may CLICK HERE or go to: Click Here You can also contact attorney Jonathan Naji, Esq.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ:ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting Click Here Investors have until December 16, 2024 to ask the Court to be appointed to lead the case.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020, and October 18, 2024, inclusive (the "Class Period").
SAN FRANCISCO, CA / ACCESSWIRE / October 31, 2024 / Acadia Healthcare Company (NASDAQ:ACHC) is facing a class-action lawsuit from investors alleging the company misled them about its business practices. The lawsuit, filed in the Middle District of Tennessee, accuses Acadia and its executives of violating the Securities Exchange Act of 1934.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q3 2024 Earnings Conference Call October 31, 2024 9:00 AM ET Company Participants Patrick Feeley – Head-Investor Relations Chris Hunter – Chief Executive Officer Heather Dixon – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Whit Mayo – Leerink Partners Brian Tanquilut – Jefferies John Ransom – Raymond James Christian Porter – Bank of America Ben Hendrix – RBC Capital Markets Pito Chickering – Deutsche Bank Andrew Mok – Barclays Sarah James – Cantor Fitzgerald Matthew Gillmor – KeyBanc Raj Kumar – Stephens Operator Good day, and welcome to Acadia Healthcare's Third Quarter of 2024 Earnings Call.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020, and October 18, 2024, inclusive (the "Class Period").
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.91 per share a year ago.